US Patent Issued to Inovio Pharmaceuticals on April 29 for "Cancer vaccines targeting MUC16 and uses thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,473, issued on April 29, was assigned to Inovio Pharmaceuticals Inc. (Plymouth Meeting, Pa.).

"Cancer vaccines targeting MUC16 and uses thereof" was invented by Jian Yan (Wallingford, Pa.), Anna Slager (Lansdale, Pa.), Bradley Garman (Glenside, Pa.) and Neil Cooch (Oreland, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen are disclosed. Methods of treating a subject with a MUC16-express...